NanoView Biosciences attracts $10 mln
Boston-based NanoView Biosciences, a provider of exosome detection and characterization solutions, has secured $10 million in Series B financing. Northpond Ventures led the round with participation from other investors that included Sands Capital Ventures and PBM Capital Group.
10 October 2018•1 min read
